High β-1,4-Galactosyltransferase-I expression in peripheral T-lymphocytes is associated with a low risk of relapse in germ-cell cancer patients receiving high-dose chemotherapy with autologous stem cell reinfusion

Survival of patients with germ-cell cancer (GCC) and primary progression or relapse after cisplatin-based first-line chemotherapy is highly heterogeneous, ranging from close to zero to more than 70%. We investigated β-1,4-Galactosyltransferase-I (B4GALT1) expression levels in peripheral lymphocytes...

Descripción completa

Detalles Bibliográficos
Autores principales: Nilius, Verena, Killer, Madeleine C., Timmesfeld, Nina, Schmitt, Melina, Moll, Roland, Lorch, Anja, Beyer, Jörg, Mack, Elisabeth, Lohoff, Michael, Burchert, Andreas, Neubauer, Andreas, Brendel, Cornelia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2018
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5927517/
https://www.ncbi.nlm.nih.gov/pubmed/29721375
http://dx.doi.org/10.1080/2162402X.2017.1423169

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5927517/
https://www.ncbi.nlm.nih.gov/pubmed/29721375
http://dx.doi.org/10.1080/2162402X.2017.1423169

Ejemplares similares